Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
May 29 SENS Senseonics Holdings, Inc. to Participate in the Sidoti Small Cap Conference
May 29 SMLR Is Now The Time To Put Semler Scientific (NASDAQ:SMLR) On Your Watchlist?
May 29 TNDM Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
May 29 TNDM Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here
May 29 ZURA Zura Bio Announces Participation in June Investor Conferences
May 28 VKTX Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?
May 28 SMLR Semler Scientific adopts bitcoin as primary treasury reserve asset
May 28 SMLR Semler Scientific® Announces Bitcoin Treasury Strategy
May 28 VTVT CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING
May 28 VANI EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use
May 27 VKTX This Biotech Stock is a “Strong Buy” According to Raymond James
May 27 VTVT Shareholders in vTv Therapeutics (NASDAQ:VTVT) are in the red if they invested three years ago
May 26 VKTX If You'd Invested $100 in Viking Therapeutics Stock 2 Years Ago, Here's How Much You'd Have Today
May 24 ZURA Zura Bio files to sell 41.6M Class A ordinary shares for holders
May 24 VKTX 2 Stocks That Could 10x by 2035
May 23 TNDM Tandem Diabetes Care Announces Upcoming Conference Presentation
May 23 SYBX The Summer Stock Exodus: 3 Companies to Ditch Before the Heat Hits
May 23 VKTX Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags